Vemurafenib in the French temporary authorization for use metastatic melanoma cohort: a single-centre trial

Fennira, Feriel; Pagès, Cecile; Schneider, Pierre; More

Melanoma Research. 24(1):75-82, February 2014.

The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity

Woods, David M.; Woan, Karrune; Cheng, Fengdong; More

Melanoma Research. 23(5):341-348, October 2013.